The weight loss drug Tirzepatide can also significantly reduce cardiac death or heart failure!
Obesity is an important risk factor for heart failure (HF), especially for heart failure with preserved ejection fraction (HFpEF). Obesity can lead to a systemic inflammatory state, which may affect the myocardium through inflammatory transformation of epicardial adipose tissue. As body mass index (BMI) increases, the risk of heart failure also increases. Weight loss interventions […]